T(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs

T. Narita; A. Inagaki; T. Kobayashi; Y. Kuroda; T. Fukushima; M. Nezu; S. Fuchida; H. Sakai; N. Sekiguchi; I. Sugiura; Y. Maeda; H. Takamatsu; N. Tsukamoto; D. Maruyama; Y. Kubota; M. Kojima; K. Sunami; T. Ono; M. Ri; K. Tobinai; S. Iida

doi:10.1038/bcj.2015.6

T(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs

T. Narita, A. Inagaki, T. Kobayashi, Y. Kuroda, T. Fukushima, M. Nezu, S. Fuchida, H. Sakai, N. Sekiguchi, I. Sugiura, Y. Maeda, H. Takamatsu, N. Tsukamoto, D. Maruyama, Y. Kubota, M. Kojima, K. Sunami, T. Ono, M. Ri, K. TobinaiS. Iida

Research output: Contribution to journal › Letter › peer-review

31 Citations (Scopus)

Original language	English
Article number	e285
Journal	Blood Cancer Journal
Volume	5
Issue number	2
DOIs	https://doi.org/10.1038/bcj.2015.6
Publication status	Published - Jan 1 2015

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1038/bcj.2015.6

Cite this

Narita, T., Inagaki, A., Kobayashi, T., Kuroda, Y., Fukushima, T., Nezu, M., Fuchida, S., Sakai, H., Sekiguchi, N., Sugiura, I., Maeda, Y., Takamatsu, H., Tsukamoto, N., Maruyama, D., Kubota, Y., Kojima, M., Sunami, K., Ono, T., Ri, M., ... Iida, S. (2015). T(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs. Blood Cancer Journal, 5(2), Article e285. https://doi.org/10.1038/bcj.2015.6

Narita, T, Inagaki, A, Kobayashi, T, Kuroda, Y, Fukushima, T, Nezu, M, Fuchida, S, Sakai, H, Sekiguchi, N, Sugiura, I, Maeda, Y, Takamatsu, H, Tsukamoto, N, Maruyama, D, Kubota, Y, Kojima, M, Sunami, K, Ono, T, Ri, M, Tobinai, K & Iida, S 2015, 'T(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs', Blood Cancer Journal, vol. 5, no. 2, e285. https://doi.org/10.1038/bcj.2015.6

@article{c4f64bbb5d4341a9af839d652a9340d5,

title = "T(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs",

author = "T. Narita and A. Inagaki and T. Kobayashi and Y. Kuroda and T. Fukushima and M. Nezu and S. Fuchida and H. Sakai and N. Sekiguchi and I. Sugiura and Y. Maeda and H. Takamatsu and N. Tsukamoto and D. Maruyama and Y. Kubota and M. Kojima and K. Sunami and T. Ono and M. Ri and K. Tobinai and S. Iida",

year = "2015",

month = jan,

day = "1",

doi = "10.1038/bcj.2015.6",

language = "English",

volume = "5",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - T(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs

AU - Narita, T.

AU - Inagaki, A.

AU - Kobayashi, T.

AU - Kuroda, Y.

AU - Fukushima, T.

AU - Nezu, M.

AU - Fuchida, S.

AU - Sakai, H.

AU - Sekiguchi, N.

AU - Sugiura, I.

AU - Maeda, Y.

AU - Takamatsu, H.

AU - Tsukamoto, N.

AU - Maruyama, D.

AU - Kubota, Y.

AU - Kojima, M.

AU - Sunami, K.

AU - Ono, T.

AU - Ri, M.

AU - Tobinai, K.

AU - Iida, S.

PY - 2015/1/1

Y1 - 2015/1/1

UR - http://www.scopus.com/inward/record.url?scp=84927939137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927939137&partnerID=8YFLogxK

U2 - 10.1038/bcj.2015.6

DO - 10.1038/bcj.2015.6

M3 - Letter

C2 - 25723856

AN - SCOPUS:84927939137

SN - 2044-5385

VL - 5

JO - Blood Cancer Journal

JF - Blood Cancer Journal

IS - 2

M1 - e285

ER -

T(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this